We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+12.16%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$43.2B
AUM Growth
+$461M
(+1.1%)
Cap. Flow
-$3.13B
Cap. Flow
% of AUM
-7.24%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
2,717
New
237
Increased
842
Reduced
1,328
Closed
284
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$438M |
| 2 |
Humana
HUM
|
+$375M |
| 3 |
Nike
NKE
|
+$306M |
| 4 |
Gilead Sciences
GILD
|
+$301M |
| 5 |
Pfizer
PFE
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$368M |
| 2 |
Merck
MRK
|
+$325M |
| 3 |
Rivian
RIVN
|
+$279M |
| 4 |
Microsoft
MSFT
|
+$266M |
| 5 |
CVS Health
CVS
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.11% |
| 2 | Healthcare | 13.15% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Financials | 11.68% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPRB
2326
Spruce Biosciences
SPRB
$114M
| $71K | ﹤0.01% |
1,204
-71
| -6% | -$18.1K |
|
2327
Gaia
GAIA
$47.6M
| $70.2K | ﹤0.01% |
22,800
-100
| -0.4% | -$292 |
|
|
ORGN
2328
DELISTED
Origin Materials
ORGN
| $68.2K | ﹤0.01% |
4,460
-680
| -13% | -$11.8K |
|
2329
Rafael Holdings
RFL
$109M
| $66.6K | ﹤0.01% |
39,242
-405
| -1% | -$708 |
|
|
ZH
2330
Zhihu
ZH
$281M
| $66.5K | ﹤0.01% |
16,217
+1,050
| +7% | +$4.92K |
|
2331
Pyxis Oncology
PYXS
$184M
| $66.5K | ﹤0.01% |
15,600
-48,600
| -76% | -$204K |
|
2332
Eton Pharmaceutcials
ETON
$1.28B
| $66.4K | ﹤0.01% |
17,700
+6,800
| +62% | +$29.7K |
|
2333
Riverview Bancorp
RVSB
$109M
| $65.1K | ﹤0.01% |
13,800
-200
| -1% | -$1.04K |
|
2334
Planet Labs
PL
$7.28B
| $64.5K | ﹤0.01% |
25,300
+8,600
| +51% | +$19.4K |
|
2335
GrowGeneration
GRWG
$88.3M
| $63.5K | ﹤0.01% |
22,200
-1,000
| -4% | -$2.31K |
|
2336
Aquestive Therapeutics
AQST
$472M
| $63K | ﹤0.01% |
14,800
-12,000
| -45% | -$39.9K |
|
2337
ReNew
RNW
$2.22B
| $61.8K | ﹤0.01% |
+10,300
| New | +$67.9K |
|
|
SYRS
2338
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $61.8K | ﹤0.01% |
+11,550
| New | +$79.9K |
|
2339
Creative Medical Technology
CELZ
$4.78M
| $61.2K | ﹤0.01% |
+11,744
| New | +$54.7K |
|
2340
Quantum-Si Incorporated
QSI
$166M
| $60.5K | ﹤0.01% |
30,700
+7,300
| +31% | +$12.8K |
|
|
AEVA
2341
Aeva Technologies
AEVA
$1B
| $57.8K | ﹤0.01% |
14,700
-51,120
| -78% | -$247K |
|
|
AFMD
2342
DELISTED
Affimed
AFMD
| $57.1K | ﹤0.01% |
10,777
-58,210
| -84% | -$332K |
|
2343
ThredUp
TDUP
$760M
| $56.6K | ﹤0.01% |
28,300
+11,600
| +69% | +$23.6K |
|
2344
Innoviz Technologies
INVZ
$99.5M
| $55.6K | ﹤0.01% |
41,200
-8,600
| -17% | -$14.4K |
|
|
LVTX
2345
DELISTED
LAVA Therapeutics
LVTX
| $55.6K | ﹤0.01% |
+16,700
| New | +$36.7K |
|
|
KNDI
2346
Kandi Technologies Group
KNDI
$63.5M
| $55.3K | ﹤0.01% |
26,100
-21,300
| -45% | -$54.6K |
|
|
RPTX
2347
DELISTED
Repare Therapeutics
RPTX
| $55.1K | ﹤0.01% |
+11,700
| New | +$75K |
|
2348
Cellectar Biosciences
CLRB
$20M
| $53.3K | ﹤0.01% |
+447
| New | +$48.4K |
|
|
EMKR
2349
DELISTED
Emcore Corp
EMKR
| $51.9K | ﹤0.01% |
15,053
-14,120
| -48% | -$66.7K |
|
|
LL
2350
DELISTED
LL Flooring Holdings, Inc.
LL
| $50.9K | ﹤0.01% |
27,800
-7,500
| -21% | -$18.1K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Advisers held 2,717 positions worth $43.2B, up 1.1% from $42.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Two Sigma Advisers withdrew a net $3.13B in Q1 2024, closing 284 positions and reducing 1,328 holdings. Its most notable exit was Rivian, an estimated $279M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Advisers opened a new position in Walmart Inc worth $461M.
- Two Sigma Advisers's largest Q1 2024 buy was Walmart Inc: 7,653,900 shares worth $461M.
- Two Sigma Advisers added most to Humana in Q1 2024, an estimated $375M increase.
- Two Sigma Advisers's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $368M.
- Two Sigma Advisers fully exited Rivian in Q1 2024, selling an estimated $279M.
- Two Sigma Advisers's ten largest holdings make up 17% of its $43.2B portfolio in Q1 2024.
- Two Sigma Advisers opened 237 new positions and closed 284 in Q1 2024.
- Two Sigma Advisers's portfolio value rose 1.1% quarter-over-quarter to $43.2B.
Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.